Prestige Consumer Healthcare
PBH
328 hedge funds and large institutions have $3.68B invested in Prestige Consumer Healthcare in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 120 increasing their positions, 105 reducing their positions, and 21 closing their positions.
110% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 21
14% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 105
7% more funds holding
Funds holding: 306 → 328 (+22)
5% more capital invested
Capital invested by funds: $3.51B → $3.68B (+$171M)
0.29% more ownership
Funds ownership: 102.75% → 103.04% (+0.29%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$41M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$18.1M |
| 3 |
Morgan Stanley
New York
|
+$13.6M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.23M |
| 5 |
Barclays
London,
United Kingdom
|
+$5.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.1M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$11.5M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$8.53M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.9M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$5.9M |
PBH Hedge Fund Activity: Q3 2024 in Review
328 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2024, worth a combined $3.68B — up 4.9% from $3.51B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new PBH positions and 21 closed out — a net gain of 23 holders — while 120 added to existing stakes and 105 trimmed.
The largest buyer was Boston Trust Walden, opening a new position worth an estimated $41M. The largest seller was Fidelity Investments, cutting an estimated $40.1M.
- 328 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2024, up from 306 in Q2 2024.
- Funds reported $3.68B of Prestige Consumer Healthcare stock for Q3 2024, up 4.9% quarter-over-quarter.
- 44 funds opened new Prestige Consumer Healthcare positions in Q3 2024 and 21 closed out, a net change of +23 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2024 was Boston Trust Walden, an estimated $41M added.
- The largest Prestige Consumer Healthcare seller in Q3 2024 was Fidelity Investments, an estimated $40.1M sold.
Based on aggregated 13F filings for Q3 2024.